SG Americas Securities’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-896
Closed -$14K 3550
2024
Q2
$14K Buy
+896
New +$15K ﹤0.01% 2778
2024
Q1
Sell
-1,133
Closed -$22K 3299
2023
Q4
$22K Buy
1,133
+221
+24% +$4.03K ﹤0.01% 2998
2023
Q3
$17K Buy
+912
New +$16.4K ﹤0.01% 3052
2020
Q3
Sell
-1,212
Closed -$135K 3238
2020
Q2
$135K Buy
+1,212
New +$86.3K ﹤0.01% 3162

Other funds holding OPTN

SG Americas Securities's OPTN Position: Q3 2024 in Review

SG Americas Securities sold out of OptiNose (OPTN) in Q3 2024, closing a stake of 896 shares — an estimated $14K sold.

SG Americas Securities first reported a position in OPTN in Q2 2020 and held it in 4 quarters. The position peaked at $135K in Q2 2020. 65 funds tracked by Wall St. Rank hold OPTN as of Q3 2024.

  • SG Americas Securities reported no remaining OptiNose position as of Q3 2024 after selling out during the quarter.
  • SG Americas Securities sold 896 OptiNose shares in Q3 2024, an estimated $14K.
  • SG Americas Securities first reported a position in OptiNose in Q2 2020 and held it in 4 quarters.
  • SG Americas Securities's OptiNose position peaked at $135K in Q2 2020.
  • 65 funds tracked by Wall St. Rank held OptiNose as of Q3 2024.

Based on SG Americas Securities's 13F filing for Q3 2024, filed 3 Oct 2024.